Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Mediclinic: stake in Swiss procurement disruptor “does not impact Sana agreement”

Switzerland's largest private hospital group Hirslanden's investment in a self-proclaimed 'disruptive' procurement outfit does not affect its cooperation with the procurement hub of German hospital Sana, parent company Mediclinic tells HBI. But the group has yet to reveal what it has gotten out of the cooperation with Sana. 

UK care homes show resilience, but in urgent need of preventative and crisis funding

According to a new report the UK care home sector is showing some resilience despite COVID-19, with occupancy steadily improving as confidence improves in the sector and care homes better prepared for an imminent risk of resurgence. Despite this, thousands remain at risk of closure and in need of stronger government support.

Optegra sales process begins

Multiple sources tell HBI that UK, Czechia and Poland-based ophthalmology platform Optegra is for sale. We take a look at the detailed figures behind the prospective sale, speculate as to price and buyers, and speak to an operator source about his view of the business.

NHS England trims operator list as PMI drives private pay recovery

We reveal which UK private hospital operators are still in NHS England's new national agreement and which left it on Tuesday, September 8. Private medical insurers (PMI) are 'busting' to get policyholders treated after delays but operators face a delicate balancing act in also helping the NHS clear waiting lists, an analyst tells HBI, as the market recovers to 70-80% of 2019 activity levels during July and August. 

EXCLUSIVE: Dutch mental health operator for sale

HBI hears that PE-backed Dutch mental health provider Mentaal Beter is for sale, with both private equity and international sector operators interested. A local consultant tells us why this is an attractive buy.

Bupa CEO steps down

The CEO of international health insurer and services group Bupa is stepping down at the age of 55 and being succeeded by an internal appointment. We ask why and look at the group's H1 results. 

Find Us